Neiges Biotechnologies Overview
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Investors
-
6
Neiges Biotechnologies General Information
Description
Developer of patient-derived tissue models designed for drug discovery and preclinical research. The company's platform produces intestinal tissue models from patient stem cells, supports molecular and cellular analysis, enables parallel testing of multiple compounds on matched samples, and generates reproducible experimental data, enabling pharmaceutical and biotechnology organizations to evaluate drug candidates and study biological responses.
Contact Information
Website
www.neigesbiotech.comCorporate Office
- 1250 Rue Guy
- Suite 600
- Montreal, Quebec H3H 2L3
- Canada
Corporate Office
- 1250 Rue Guy
- Suite 600
- Montreal, Quebec H3H 2L3
- Canada
Neiges Biotechnologies Timeline
Neiges Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | Completed | Startup | ||||
| 6. Accelerator/Incubator | 01-Jan-2026 | Completed | Startup | |||
| 5. Accelerator/Incubator | 08-Sep-2025 | Completed | Startup | |||
| 4. Accelerator/Incubator | 28-May-2025 | Completed | Startup | |||
| 3. Grant | 03-Mar-2025 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Oct-2023 | Completed | Startup | |||
| 1. University Spin-Out | Completed | Startup |
Neiges Biotechnologies Signals
Neiges Biotechnologies Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Merck Digital Sciences Studio | Accelerator/Incubator | Minority | ||
| District 3 Innovation Center | Accelerator/Incubator | |||
| McGill University | University | |||
| V1 Studio | Accelerator/Incubator | |||
| Front Row Ventures | Venture Capital | Minority |
Neiges Biotechnologies FAQs
-
Where is Neiges Biotechnologies headquartered?
Neiges Biotechnologies is headquartered in Montreal, Canada.
-
What is the size of Neiges Biotechnologies?
Neiges Biotechnologies has 3 total employees.
-
What industry is Neiges Biotechnologies in?
Neiges Biotechnologies’s primary industry is Drug Discovery.
-
Is Neiges Biotechnologies a private or public company?
Neiges Biotechnologies is a Private company.
-
What is Neiges Biotechnologies’s current revenue?
The current revenue for Neiges Biotechnologies is .
-
How much funding has Neiges Biotechnologies raised over time?
Neiges Biotechnologies has raised $110K.
-
Who are Neiges Biotechnologies’s investors?
Merck Digital Sciences Studio, District 3 Innovation Center, McGill University, V1 Studio, and Front Row Ventures are 5 of 6 investors who have invested in Neiges Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process